Collaborative project extends Rhenovia's innovative CNS biosimulation platform to study of epilepsy
Rhenovia Pharma SAS, a biopharmaceutical company specialized in the development of technologies to optimize the discovery and development of drugs for Alzheimer's and other diseases of the central and peripheral nervous system, has been named leader of RHENEPI, a EUR 2.5 million (USD 3.75M) project. The goals of RHENEPI are to develop and obtain experimental validation for an epilepsy biosimulation platform that can be used for the discovery of new antiepileptic drugs and the optimization of existing drugs.
Read more ...
EU-funded study investigates kidney regeneration potential
A paper published in The Lancet journal, as part of a series on renal medicine, has questioned if kidney regeneration may be possible in human beings as it is in fish and other lower vertebrates. The work is part of an ongoing EU-funded research project on the possibilities of kidney regeneration, and was carried out by a team from the Mario Negri Institute for Pharmacological Research in Bergamo, Italy.
Read more ...
Enzyme in white blood cells can break down carbon nanotubes
An EU-funded study of carbon nanotubes by scientists in Ireland, Sweden and the US has shown that these extraordinarily strong molecules can be broken down into carbon and water by an enzyme found in white blood cells. The discovery, published in the journal Nature Nanotechnology, offers hope that this new material may be exploited safely in medicine and industry.
Read more ...
Biocitech technology park posts record number of partnerships in 2009
Biocitech SAS, the Paris life science technology park, announced that its 23 resident companies exceeded past performance again in 2009 with a significant increase in the number of agreements concluded with pharmaceutical and biopharmaceutical companies outside Biocitech. Biocitech has drawn attention in the past to the excellent working relationships forged between residents, and 2009 shows how successfully the residents are working internationally and with other companies in France.
Read more ...
Novoseek in the Virtual Library of the Spanish Council for Scientific Research
Novoseek, the free biomedical search engine developed by the bioinformatics company Bioalma, has been incorporated to electronic information resources available at the Spanish Council of Scientific Research (CSIC). This integration will permit members of the CSIC to access novoseek directly from the CSIC Virtual Library. All the novoseek users belonging to the CSIC, will find a direct link of to complete documents available at the CSIC Virtual Library.
Read more ...
Theranostics Paves the Way for Personalised Medicine in Europe
Theranostics is an emerging field in clinical diagnostics, focussing on developing specific analysis to predict the most suitable drug for a patient along with assessing the efficacy of the drug. It uses molecular assays to determine the optimum dose of drugs for a patient, paving the way for personalised medicine. Although significant awareness has been created about personalised medicine, its full potential is yet to be tapped.
Read more ...
New study highlights immune system's role in Alzheimer's
The brain's immune cells may be behind the loss of neurons associated with Alzheimer's disease, new EU-funded research suggests. The findings, published in the journal Nature Neuroscience, could lead to the development of new treatments for the neurodegenerative disease.
Read more ...